Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$185,487,482
-$25,808,196 QoQ
Shares Held
8,332,771
+5.3% QoQ
Ownership
4.87%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 8.405523204705853.ToString("F0")%
Shared 0.020401376684898696.ToString("F0")%
None 91.57407541860924.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. ACAD ranks #35 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $185,487,482 | 8,332,771 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $211,295,678 | 7,910,733 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $154,831,857 | 7,255,476 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $133,260,409 | 6,178,044 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $116,162,250 | 6,993,513 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $82,967,414 | 4,521,385 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $91,878,182 | 5,973,874 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $94,262,837 | 5,800,790 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $110,965,941 | 6,001,403 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $202,419,964 | 6,465,026 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $108,654,154 | 5,213,731 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $129,816,616 | 5,420,318 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $105,144,724 | 5,586,861 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $123,226,180 | 7,740,338 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $110,902,329 | 6,778,871 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $92,908,755 | 6,593,950 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $122,485,238 | 5,057,194 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $112,497,703 | 4,819,953 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $95,147,445 | 5,728,323 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $96,843,202 | 3,970,611 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $82,782,860 | 3,208,638 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $139,521,297 | 2,609,826 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $111,481,590 | 2,702,584 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $124,458,551 | 2,567,744 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $170,787,006 | 4,042,296 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||